Antidiabetic Oral Treatment in Older People

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Drugs & Aging

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/11534660-000000000-00000PMID 20136169
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors

  2009cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Is there a relationship between insulin resistance and frailty syndrome?

  2008cited by this paper
• Diabetes, sarcopenia, and frailty.

  2008cited by this paper
• Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.

  2008cited by this paper
• New Approaches to Treating Type 2 Diabetes Mellitus in the Elderly

  2008cited by this paper
• Effect of Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin on Glycemic Control in Patients With Type 2 Diabetes

  2008cited by this paper
• Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.

  2007cited by this paper
• Individualising Therapy for Older Adults with Diabetes Mellitus

  2007cited by this paper
• [Commentary to the article: Kahn SE, Haffner SM, Heise MA, et al. ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355: 2427-43].

  2007cited by this paper
• Relation of diabetes to mild cognitive impairment.

  2007cited by this paper
• Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

  2007cited by this paper
• The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial.

  2007cited by this paper
• Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

  2007cited by this paper
• Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

  2007cited by this paper
• Establishing pragmatic estimated GFR thresholds to guide metformin prescribing

  2007cited by this paper
• Glycemia and cognitive function in older adults using glucose-lowering drugs.

  2006cited by this paper
• Research Agenda for Frailty in Older Adults: Toward a Better Understanding of Physiology and Etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults

  2006cited by this paper
• Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

  2006cited by this paper
• Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics

  2006cited by this paper
• Safety of Type 2 Diabetes Treatment With Repaglinide Compared With Glibenclamide in Elderly People

  2006cited by this paper
• Improving metabolic control leads to better working memory in adults with type 2 diabetes.

  2006cited by this paper
• The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

  2006cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.

  2005cited by this paper
• The effect of diabetes on disability in middle-aged and older adults.

  2005cited by this paper
• Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.

  2005cited by this paper
• Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies

  2005cited by this paper
• Treatment of diabetes in the elderly

  2005cited by this paper
• Thiazolidinediones, Metformin, and Outcomes in Older Patients With Diabetes and Heart Failure: An Observational Study

  2005cited by this paper
• Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.

  2005cited by this paper
• Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes.

  2005cited by this paper
• Insulin Resistance and Executive Dysfunction in Older Persons

  2004cited by this paper
• Repaglinide versus nateglinide monotherapy: a randomized, multicenter study.

  2004cited by this paper
• Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.

  2004cited by this paper
• Frailty in the elderly: contributions of sarcopenia and visceral protein depletion.

  2003cited by this paper
• Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

  2003cited by this paper
• Progression of lower-extremity disability in older women with diabetes: the Women's Health and Aging Study.

  2003cited by this paper
• Metformin and its liver targets in the treatment of type 2 diabetes.

  2003cited by this paper
• Pharmacology of the Meglitinide Analogs

  2003cited by this paper
• Diabetes as a predictor of change in functional status among older Mexican Americans: a population-based cohort study.

  2003cited by this paper
• Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study.

  2002cited by this paper
• Ageing and diabetes: implications for brain function.

  2002cited by this paper
• Older women with diabetes have a higher risk of falls: a prospective study.

  2002cited by this paper
• Comorbidities and impairments explaining the association between diabetes and lower extremity disability: The Women's Health and Aging Study.

  2002cited by this paper
• Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.

  2002cited by this paper
• Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study.

  2001cited by this paper
• Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort.

  2001cited by this paper
• Gliclazide modified release: its place in the therapeutic armamentarium.

  2000cited by this paper
• Diabetes and physical disability among older U.S. adults.

  2000cited by this paper
• Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

  1999cited by this paper
• Toward an Understanding of Frailty

  1999cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994

  1998cited by this paper
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996cited by this paper
• RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

  1996cited by this paper
• Management of diabetes in the elderly: a clinical perspective.

  1994cited by this paper
• Biological Effects and Metabolic Rates of Glucagonlike Peptide-1 7–36 Amide and Glucagonlike Peptide-1 7–37 in Healthy Subjects Are Indistinguishable

  1993cited by this paper
• The physics of frailty.

  1993cited by this paper
• On the Birth of a New Journal

  1978cited by this paper
• Non-insulin-dependent Diabetes Mellitus (niddm) Association of Diabetes Mellitus and Dementia: the Rotterdam Study

  year unknowncited by this paper

• Determination of the relationship between frailty level and quality of life in elderly individuals with type 2 diabetes

  2024cites this paper
• Frailty and chronic diseases: A bi‐directional relationship

  2024cites this paper
• The Impact of Glucose-Lowering Strategy on the Risk of Increasing Frailty Severity among 49,519 Patients with Diabetes Mellitus: A Longitudinal Cohort Study

  2023cites this paper
• Health in Men Study: is frailty a predictor of medication-related hospitalization?

  2020cites this paper
• Diabetes Mellitus in the Elderly

  2017cites this paper
• Features of sarcopenia and body composition on the basis of bioimpedance measurements in patients with type 2 diabetes mellitus

  2017cites this paper
• Knowledge Confidence and Desire for Further Diabetes-Management Education among Nurses and Personal Support Workers in Long-Term Care.

  2016cites this paper
• Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA study.

  2015cites this paper
• New Guidelines for Elderly Diabetic Patients

  2015cites this paper
• Dipeptidyl peptidase‐4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes

  2015cites this paper
• Antihyperglycemic Medications and Hypoglycemia in Older Adults with Diabetes

  2015cites this paper
• Older people with diabetes - avoiding hospitalization

  2015cites this paper
• REDUCTION OF HYPERGLYCAEMIA WITH ETHANOLIC EXTRACT OF SCOPARIA DULCIS L. IN DOSE DEPENDENT MANNER

  2014cites this paper
• Management of diabetes mellitus type-2 in the geriatric population: Current perspectives

  2014cites this paper
• Frailty, sarcopenia and diabetes.

  2014cites this paper
• Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists

  2014cites this paper
• Diabetic kidney disease in elderly individuals.

  2013cites this paper
• Inhibitory DPP-4 u osób starszych – bezpieczeństwo i skuteczność w jednym?

  2013cites this paper
• TRENDS IN THERAPEUTIC INTERVENTIONS IN PATIENTS WITH DIABETES MELLITUS IN SAUDI ARABIA

  2013cites this paper
• Objetivo terapéutico en el anciano frágil. No siempre más es mejor

  2012cites this paper
• Diabetes Mellitus in Older Adults

  2012cites this paper
• Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009

  2012cites this paper
• Antidiabetic Drugs for Elderly Population

  2012cites this paper
• 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial.

  2012cites this paper
• Polypharmacy and Food–Drug Interactions Among Older Persons: A Review

  2012cites this paper
• Frailty and Safety

  2012cites this paper
• Incretin Therapies in the Management of Patients with Type 2 Diabetes Mellitus and Renal Impairment

  2012cites this paper
• Metformin in obesity, cancer and aging: addressing controversies

  2012cites this paper
• Older patients, multiple comorbidities, polymedication… should we treat everything?

  2011cites this paper
• Incretin Therapies in the Management of Elderly Patients with Type 2 Diabetes Mellitus

  2011influential citation
• Special Considerations with Insulin Therapy in Older Adults with Diabetes Mellitus

  2011cites this paper
• Effect of Sitagliptin as Add-on Therapy in Elderly Type 2 Diabetes Patients With Inadequate Glycemic Control in Taiwan †

  2011cites this paper
• Choosing Targets for Glycaemia, Blood Pressure and Low-Density Lipoprotein Cholesterol in Elderly Individuals with Diabetes Mellitus

  2011cites this paper
• Synthesis and antidiabetic activity of β-acetamido ketones

  2011cites this paper
• This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Management of Global Cardiovascular Risk in Older Subjects with Diabetes Mellitus

  2010cites this paper